# Cytology of the Respiratory Tract in Dogs and Cats ## Quick Answer - Bronchoalveolar lavage (BAL) cytology is the primary laboratory method for differentiating infectious, inflammatory, and neoplastic respiratory disease in dogs and cats, with sample quality directly determining diagnostic reliability. - Collect samples via bronchoscopic or blind BAL techniques, prepare them promptly using cytocentrifugation when available, and interpret differential cell counts alongside clinical signs and historical findings. - Cytologic interpretation requires correlation with culture, imaging, and signalment because overlapping cellular patterns occur across disease categories and sample handling artifacts can mimic pathology. ## Clinical Indications for Respiratory Cytology Respiratory cytology serves a defined diagnostic role in companion animal medicine when clinical signs point to lower airway disease. The decision to pursue cytologic sampling arises after physical examination, thoracic radiography, and basic hematology fail to establish a definitive cause for coughing, dyspnea, tachypnea, or abnormal lung sounds. The American Veterinary Medical Association emphasizes that pet owners should maintain regular veterinary engagement for preventive care and early disease detection, which supports timely diagnostic intervention when respiratory signs appear [1]. Similarly, the American Animal Hospital Association provides practice guidance that frames diagnostic procedures within the context of life-stage appropriate care, recognizing that respiratory disease presentation varies with patient age and underlying comorbidities [2]. Cytology of the respiratory tract becomes clinically valuable in several specific scenarios. First, when radiographic findings reveal an interstitial or alveolar pattern that could represent pneumonia, pulmonary edema, hemorrhage, or neoplasia, cytology helps narrow the differential list. Second, when a patient fails to respond to empirical antimicrobial therapy for suspected bacterial pneumonia, cytology with concurrent culture identifies whether inflammation is infectious, eosinophilic, or neoplastic in origin. Third, when chronic cough persists despite treatment for presumed tracheobronchitis or bronchial disease, BAL cytology characterizes the inflammatory cell population and guides targeted therapy. Fourth, when thoracic radiographs identify a mass lesion, cytologic sampling via bronchial brushing or fine-needle aspiration can provide a preliminary tissue diagnosis before surgical biopsy is considered. The World Small Animal Veterinary Association global guidelines recognize that diagnostic decision-making should follow standardized clinical approaches that balance diagnostic yield with patient welfare [3]. Respiratory cytology fits within this framework as a minimally invasive procedure that can be performed during bronchoscopy or as a blind technique in patients where general anesthesia carries acceptable risk. The Merck Veterinary Manual describes bronchoalveolar lavage as a diagnostic procedure used to sample the cellular and fluid components of the lower airways, providing information that complements radiographic and endoscopic findings [4]. Patient selection requires careful assessment of anesthetic risk. Animals with severe respiratory distress, significant hypoxemia, or unstable cardiovascular status may not tolerate the procedure. In such cases, the clinician must weigh the diagnostic value of cytology against the potential for procedure-related complications. Cornell University College of Veterinary Medicine resources describe the importance of thorough diagnostic evaluation in veterinary patients, noting that procedures should be tailored to the individual patient's condition and risk profile [5]. The decision to proceed with BAL should involve discussion with the owner about the expected diagnostic yield, the risks of anesthesia, and alternative diagnostic approaches. ## Anatomy and Sample Site Selection The respiratory tract presents distinct cytologic sampling challenges at each anatomic level. The upper airway, including the nasal cavity, pharynx, and larynx, can be sampled by swabs, brushings, or lavage. The trachea and mainstem bronchi are accessible via endotracheal intubation and bronchoscopic guidance. The lower airways, including the bronchioles and alveoli, require BAL for adequate sampling because surface brushing cannot reach these distal regions. Tracheobronchoscopy provides direct visualization of the airway lumen and allows the operator to identify mucosal abnormalities, masses, foreign bodies, and excessive secretions. A nomenclature system developed for canine endobronchial anatomy enables systematic identification of bronchial segments during bronchoscopy, improving communication of findings and ensuring thorough examination [8]. This systematic approach matters for cytology because sampling from the correct bronchial segment increases the likelihood of obtaining diagnostic material from the diseased region instead of from unaffected airways. The choice between tracheal wash and BAL depends on the suspected disease location. Tracheal wash samples primarily the large airways and is simpler to perform, often without bronchoscopic guidance. However, tracheal wash cytology may not accurately reflect alveolar disease because the cellular population in the trachea differs from that in the alveoli. BAL samples the bronchoalveolar space and provides a more representative picture of parenchymal inflammation. For diffuse interstitial or alveolar disease, BAL is the preferred sampling method. For focal mass lesions visible on bronchoscopy, direct brushing or forceps biopsy of the lesion yields more diagnostic material than BAL. Feline patients present additional anatomic considerations. The feline lower airways are smaller than those of most dogs, and bronchoscopic examination requires smaller-diameter endoscopes. Blind BAL techniques using a sterile catheter passed through an endotracheal tube can be performed in cats when bronchoscopy is unavailable. The volume of lavage fluid must be adjusted to the patient's size to avoid excessive fluid administration and potential respiratory compromise. ## Sample Collection Techniques ### Bronchoscopic Bronchoalveolar Lavage Bronchoscopic BAL is performed under general anesthesia with the patient intubated. The bronchoscope is advanced through the endotracheal tube into the trachea and then into the selected bronchus. Once the bronchoscope is wedged in a bronchial segment, aliquots of sterile saline are instilled through the biopsy channel and immediately aspirated. The recovered fluid contains cells from the bronchoalveolar space. The volume of lavage fluid varies with patient size. Small dogs and cats typically receive 10 to 20 mL total in divided aliquots, while larger dogs may receive 20 to 50 mL. The recovered volume is typically 40 to 60 percent of the instilled volume. Multiple aliquots may be pooled for analysis, although some laboratories prefer to examine the first aliquot separately because it contains a higher proportion of bronchial cells while subsequent aliquots are more alveolar in origin. The bronchoscopic approach offers several advantages. Direct visualization confirms that the sampling catheter is positioned in the diseased lung region. The operator can observe mucosal abnormalities, collect brushings or biopsies from visible lesions, and perform BAL in the specific lobe identified as abnormal on radiographs. The procedure also allows assessment of airway dynamics, including collapse or excessive mucus production. ### Blind Bronchoalveolar Lavage Blind BAL is performed without bronchoscopic guidance. A sterile catheter or feeding tube is passed through the endotracheal tube and advanced until resistance is felt, indicating that the catheter has wedged in a distal airway. Lavage fluid is instilled and aspirated in the same manner as bronchoscopic BAL. Blind BAL is less expensive and requires less specialized equipment than bronchoscopic BAL. It can be performed in general practice settings where bronchoscopy is unavailable. However, the operator cannot confirm the sampling location, and the sample may not originate from the most affected lung region. This limitation is particularly relevant for focal disease processes where sampling from unaffected lung could yield misleading results. The choice between bronchoscopic and blind BAL depends on available equipment, patient factors, and the suspected disease distribution. For diffuse disease such as eosinophilic bronchopneumopathy or interstitial pneumonia, blind BAL may provide adequate diagnostic material. For focal lesions or when concurrent airway examination is needed, bronchoscopic BAL is preferred. ### Tracheal Wash Tracheal wash is a simpler technique that samples the tracheal and mainstem bronchial surfaces. A sterile catheter is passed through an endotracheal tube, and a small volume of sterile saline is instilled and aspirated. The recovered fluid contains cells from the tracheal mucosa and any exudate present in the large airways. Tracheal wash is easier to perform and requires less anesthesia time than BAL. It may be adequate for diagnosing tracheobronchitis or identifying bacterial infection in the large airways. However, tracheal wash cytology does not reliably reflect alveolar disease. In patients with interstitial pneumonia or eosinophilic lung disease, tracheal wash may show minimal abnormalities while BAL reveals significant inflammation. ### Bronchial Brushing and Fine-Needle Aspiration Bronchial brushing is performed during bronchoscopy by advancing a cytology brush through the biopsy channel and abrading the mucosal surface of a visible lesion. The brush is then withdrawn and the collected cells are transferred to glass slides for staining. This technique is particularly useful for exophytic masses or mucosal lesions that can be directly visualized. Fine-needle aspiration of pulmonary masses can be performed percutaneously under ultrasound or computed tomography guidance. This technique samples solid lesions directly and can provide a cytologic diagnosis of neoplasia. However, percutaneous aspiration carries a risk of pneumothorax, particularly for small or deeply located lesions. The procedure should be performed with imaging guidance and careful patient monitoring. ## Sample Preparation and Staining ### Immediate Processing The quality of cytologic preparations depends on prompt processing of the lavage fluid. Cells begin to degenerate within minutes of collection, and delayed processing can render the sample nondiagnostic. The lavage fluid should be kept on ice if processing is delayed, although refrigeration does not completely prevent cellular degeneration. The recovered fluid should be assessed for gross appearance. Bloody fluid may indicate hemorrhage from the procedure itself or from underlying disease. Turbid fluid suggests high cellularity or the presence of exudate. Mucoid fluid indicates excessive mucus production. These gross findings should be recorded because they contribute to the overall interpretation. ### Cytocentrifugation Cytocentrifugation is generally considered the method of choice for preparing BAL samples for cytologic examination. This technique concentrates cells onto a small area of a glass slide while preserving cellular morphology. The resulting preparation allows accurate differential cell counts and detailed assessment of cellular features. A study comparing cytocentrifuged preparations with sediment smears in horses with severe equine asthma found poor concordance in differential cell counts between the two methods, although both allowed diagnostic recognition of severe neutrophilic lung disorders [11]. The authors concluded that sediment smear preparation remains useful in general practice settings where cytocentrifugation is unavailable, but it cannot be considered a comparable alternative for accurate differential cell counting [11]. This finding has direct relevance for veterinary practitioners who must decide whether to invest in cytocentrifugation equipment or rely on simpler preparation methods. ### Sediment Smears Sediment smears are prepared by centrifuging the lavage fluid to pellet the cells, then smearing the pellet onto a glass slide. This method is simpler and requires less specialized equipment than cytocentrifugation. However, the resulting preparation may be thicker and less evenly distributed, making differential cell counts more difficult and less accurate. The choice between cytocentrifugation and sediment smears should be guided by the diagnostic question. If the primary goal is to identify the predominant inflammatory cell type, sediment smears may provide adequate information. If precise differential cell counts are needed for monitoring disease progression or response to therapy, cytocentrifugation is preferred. ### Staining Methods Romanowsky-type stains, including Diff-Quik and Wright-Giemsa, are the most commonly used stains for respiratory cytology. These stains provide good nuclear and cytoplasmic detail and allow identification of inflammatory cells, epithelial cells, and infectious organisms. The staining protocol should be standardized to ensure consistent results across samples. Special stains may be useful in specific circumstances. Prussian blue staining identifies hemosiderin within macrophages, which is relevant for diagnosing pulmonary hemorrhage. Periodic acid-Schiff staining can highlight fungal organisms. Gram staining can help characterize bacterial populations, although culture remains the definitive method for bacterial identification. ## Cytologic Interpretation ### Normal Cellular Population Normal BAL fluid contains predominantly alveolar macrophages, with smaller numbers of lymphocytes, neutrophils, and occasionally eosinophils. The expected differential cell counts in healthy dogs and cats are approximately 70 to 80 percent macrophages, 5 to 10 percent lymphocytes, 5 to 10 percent neutrophils, and less than 5 percent eosinophils. Ciliated epithelial cells may be present, particularly in samples that include bronchial components. The presence of goblet cells or excessive mucus suggests chronic airway irritation. Charcot-Leyden crystals may be seen in samples with high eosinophil counts. These crystals are elongated structures formed from eosinophil granule contents and indicate significant eosinophilic inflammation. ### Neutrophilic Inflammation Neutrophilic inflammation is characterized by a predominance of neutrophils in the BAL fluid. This pattern is most commonly associated with bacterial pneumonia, but it can also occur with aspiration pneumonia, fungal infection, or noninfectious inflammatory conditions. The presence of degenerate neutrophils with intracellular bacteria strongly supports bacterial pneumonia. Degenerate neutrophils have swollen, pale nuclei and loss of cytoplasmic detail. Intracellular bacteria confirm active phagocytosis and support a diagnosis of bacterial infection. However, the absence of visible bacteria does not exclude bacterial pneumonia, particularly if the patient has received antimicrobial therapy before sampling. BAL cytology should be interpreted in conjunction with bacterial culture and antimicrobial susceptibility testing. The Merck Veterinary Manual describes the importance of culture for confirming bacterial infection and guiding antimicrobial selection [4]. Cytology can identify the inflammatory pattern, but culture provides definitive identification of the causative organism. ### Eosinophilic Inflammation Eosinophilic inflammation is characterized by a predominance of eosinophils in the BAL fluid. This pattern is associated with eosinophilic bronchopneumopathy, feline asthma, parasitic infection, and hypersensitivity reactions. The eosinophil count may exceed 20 percent of the total cell population in affected animals. Feline asthma is a common cause of eosinophilic airway inflammation in cats. Affected cats typically present with chronic cough, wheezing, and increased respiratory effort. BAL cytology reveals eosinophilic inflammation, and treatment focuses on reducing airway inflammation and avoiding triggers. The World Small Animal Veterinary Association guidelines recognize the importance of standardized diagnostic approaches for chronic respiratory conditions in companion animals [3]. Eosinophilic bronchopneumopathy in dogs presents with similar cytologic findings. Affected dogs may have peripheral eosinophilia, although this is not always present. BAL cytology is essential for diagnosis because radiographic findings are often nonspecific. ### Macrophage Predominance and Hemosiderosis Macrophage-predominant inflammation may indicate resolving pneumonia, aspiration, hemorrhage, or chronic airway disease. The presence of hemosiderin-laden macrophages indicates previous pulmonary hemorrhage. Hemosiderin is an iron-containing pigment that accumulates in macrophages after phagocytosis of red blood cells. A retrospective study of BAL samples from dogs and cats with respiratory disease found hemosiderin in 7.6 percent of canine samples and 52.9 percent of feline samples [10]. Cats were 13.33 times more likely to have pulmonary hemosiderosis on BAL cytology compared with dogs [10]. In dogs, increased respiratory rates, prolonged BAL times, concurrent transthoracic fine-needle aspiration, and cytologic diagnoses were associated with an increased risk of hemosiderosis [10]. No specific risk factors were identified for cats [10]. The high prevalence of hemosiderosis in feline BAL samples suggests that pulmonary hemorrhage is common in cats with respiratory disease. This finding has diagnostic implications because hemosiderin-laden macrophages may be mistaken for other cellular changes. The study authors noted that hemosiderosis is associated with a diverse range of disease conditions, indicating that this finding is not specific for any particular diagnosis [10]. ### Lymphocytic Inflammation Lymphocytic inflammation is less common than neutrophilic or eosinophilic patterns. Increased lymphocyte counts may be seen with chronic antigenic stimulation, lymphoma, or lymphocytic interstitial pneumonia. The presence of atypical lymphocytes with large nuclei and prominent nucleoli raises concern for lymphoma, although flow cytometry or immunophenotyping may be needed for definitive diagnosis. ### Neoplastic Cells Neoplastic cells may be identified in BAL fluid from animals with pulmonary neoplasia. Primary lung tumors, particularly adenocarcinoma, can exfoliate cells into the airway lumen. Metastatic tumors may also shed cells into the bronchoalveolar space. The cytologic features of malignancy include increased nuclear-to-cytoplasmic ratio, nuclear pleomorphism, prominent nucleoli, and abnormal chromatin patterns. The sensitivity of BAL cytology for detecting neoplasia is variable. Some tumors exfoliate readily and are easily identified, while others are more cohesive and do not shed cells into the airway. Bronchial brushing of visible masses may yield a higher diagnostic rate than BAL alone. In cases where cytology is suspicious but not diagnostic for neoplasia, histopathologic biopsy is recommended for definitive diagnosis. ### Infectious Organisms BAL cytology can identify various infectious organisms, including bacteria, fungi, and parasites. Bacterial pneumonia may show intracellular bacteria within neutrophils. Fungal organisms such as Aspergillus, Cryptococcus, and Histoplasma may be identified based on their characteristic morphology. Parasitic larvae or eggs may be seen in animals with lungworm infection. The sensitivity of cytology for detecting infectious organisms is limited by the number of organisms present and the quality of the preparation. Culture and molecular testing provide more sensitive detection methods. The Merck Veterinary Manual describes the role of laboratory testing in confirming infectious disease diagnoses [4]. ## At a Glance | Sample Type | Best Indication | Key Advantage | Primary Limitation | |-------------|-----------------|---------------|-------------------| | Bronchoscopic BAL | Diffuse lower airway or alveolar disease | Direct visualization, targeted sampling, concurrent biopsy possible | Requires bronchoscopy equipment and general anesthesia | | Blind BAL | Diffuse disease when bronchoscopy unavailable | Simpler, less expensive, less specialized equipment | Cannot confirm sampling location, may miss focal lesions | | Tracheal wash | Large airway disease, tracheobronchitis | Easy to perform, minimal equipment | Does not accurately reflect alveolar disease | | Bronchial brushing | Visible endobronchial masses | Direct sampling of lesions | Limited to lesions visible on bronchoscopy | | Percutaneous FNA | Peripheral pulmonary masses | Direct sampling of solid lesions | Risk of pneumothorax, may not sample alveolar disease | ## Differential Cell Counting and Reporting Accurate differential cell counting requires a systematic approach. A minimum of 200 to 400 cells should be counted to obtain reliable percentages. The count should be performed on a well-stained, evenly distributed area of the slide where cells are not overlapping or distorted. The reporting of BAL cytology should include the total nucleated cell count, the differential cell percentages, and a description of any abnormal cellular features. The presence of infectious organisms, hemosiderin-laden macrophages, mucus, or cellular debris should be noted. The report should also comment on sample quality, including the degree of blood contamination and the presence of epithelial cells. Standardized reporting facilitates comparison of results across time points and between patients. This is particularly important for monitoring response to therapy in chronic conditions such as feline asthma or eosinophilic bronchopneumopathy. Serial BAL cytology can document resolution of inflammation or identify persistent disease requiring treatment adjustment. ## Correlation with Clinical Findings Cytologic interpretation should never occur in isolation. The cellular pattern in BAL fluid must be correlated with the patient's signalment, history, clinical signs, radiographic findings, and results of other diagnostic tests. A neutrophilic BAL in a dog with acute onset cough, fever, and cranioventral alveolar infiltrates strongly supports bacterial pneumonia. The same cytologic finding in a dog with chronic cough and no radiographic abnormalities might suggest aspiration or noninfectious inflammatory disease. The American Veterinary Medical Association emphasizes the importance of comprehensive veterinary care that includes diagnostic testing when clinically indicated [1]. Similarly, the American Animal Hospital Association practice guidance supports evidence-based diagnostic decision-making in companion animal practice [2]. These professional standards underscore the need for cytologic findings to be integrated into the complete clinical picture instead of interpreted as standalone results. Signalment plays an important role in interpretation. Young animals are more likely to have infectious pneumonia or parasitic disease. Older animals have a higher prevalence of neoplasia. Brachycephalic breeds are predisposed to aspiration pneumonia. Cats with chronic cough are more likely to have feline asthma than bacterial pneumonia. ## Common Failure Patterns and Pitfalls ### Inadequate Sample Collection The most common cause of nondiagnostic BAL cytology is inadequate sample collection. If the recovered fluid volume is low, the cellular yield may be insufficient for interpretation. If the catheter is not properly wedged in a bronchus, the fluid may reflux into the trachea and sample predominantly bronchial instead of alveolar cells. If the patient has significant airway collapse, the catheter may not advance to the desired location. ### Delayed Processing Cellular degeneration begins immediately after collection. Delayed processing can result in pyknosis, karyorrhexis, and loss of cytoplasmic detail, making accurate cell identification difficult. Samples should be processed within 30 to 60 minutes of collection whenever possible. ### Blood Contamination Blood contamination can dilute the BAL sample and interfere with cell counting. The presence of peripheral blood cells may be mistaken for inflammation, particularly if the blood is from the sampling procedure itself. The degree of blood contamination should be assessed by the presence of erythrocytes and the ratio of erythrocytes to nucleated cells. ### Overinterpretation of Artifacts Various artifacts can mimic pathologic findings. Ciliated epithelial cells may be mistaken for neoplastic cells. Mucus strands can obscure cellular detail. Stain precipitate can be mistaken for bacteria. The cytologist must be familiar with these artifacts to avoid false-positive diagnoses. ### Failure to Correlate with Culture Cytology alone cannot definitively diagnose bacterial pneumonia. The absence of visible bacteria on cytology does not exclude infection, particularly in patients who have received antimicrobial therapy. Conversely, the presence of bacteria on cytology does not confirm infection if the organisms are contaminants from the upper airway. Bacterial culture of BAL fluid provides definitive identification and antimicrobial susceptibility data. ## Preparation Method Comparison | Preparation Method | Equipment Required | Differential Count Accuracy | Best Use Setting | |-------------------|-------------------|----------------------------|------------------| | Cytocentrifugation | Cytocentrifuge, specialized funnels | High, preserves cell morphology | Reference laboratories, specialty hospitals | | Sediment smear | Standard centrifuge, glass slides | Lower, poor concordance with cytocentrifugation | General practice where cytocentrifuge unavailable | | Direct smear | No centrifugation | Variable, depends on fluid cellularity | High-cellularity samples, rapid assessment | The comparison between cytocentrifugation and sediment smear preparation has been formally evaluated in equine asthma research. A study of 48 BAL samples from six horses with severe equine asthma found poor concordance in differential cell counts between cytocentrifuged preparations and sediment smears, although both methods allowed diagnostic recognition of severe neutrophilic lung disorders [11]. The researchers concluded that sediment smear preparation remains useful in general equine practice when a cytocentrifuge is unavailable, but it cannot be considered a comparable alternative for accurate differential cell counting [11]. Veterinary practitioners should consider this evidence when deciding whether to invest in cytocentrifugation equipment for their practice. ## Welfare and Safety Considerations Respiratory cytology procedures require general anesthesia, which carries inherent risks. The World Organisation for Animal Health emphasizes that animal health and welfare should be prioritized in all veterinary procedures [6]. The anesthetic protocol should be tailored to the patient's cardiovascular and respiratory status, and monitoring should continue throughout the procedure and recovery period. Complications of tracheobronchoscopy are uncommon, but patients must be carefully monitored during the procedure because complications may be severe and life-threatening when they occur [8]. Potential complications include hypoxemia, bronchospasm, hemorrhage, pneumothorax, and cardiac arrhythmias. The operator should be prepared to manage these complications promptly. The decision to perform respiratory cytology should balance the diagnostic value of the procedure against the risks of anesthesia and instrumentation. In patients with severe respiratory compromise, the procedure may be deferred until the patient is stabilized. In patients with coagulopathies, the risk of hemorrhage may preclude bronchial brushing or biopsy. Owners should be informed of the risks and benefits of the procedure before consent is obtained. The American Veterinary Medical Association pet owner resources emphasize the importance of open communication between veterinarians and pet owners regarding diagnostic and treatment decisions [1]. This communication should include a discussion of the expected diagnostic yield, the risks of the procedure, and alternative diagnostic approaches. ## Records and Documentation Accurate records are essential for respiratory cytology procedures. The medical record should document the indication for the procedure, the sampling technique used, the volume of fluid instilled and recovered, the gross appearance of the fluid, and any complications encountered. The cytology report should be filed with the medical record, and the results should be discussed with the owner. Serial cytology results should be compared to assess response to therapy. The differential cell counts from each sampling should be recorded in a format that allows easy comparison. Changes in the predominant cell type or the degree of inflammation can guide treatment adjustments. The World Organisation for Animal Health emphasizes the importance of surveillance and reporting in animal health [6]. While individual patient records are not typically reported to regulatory authorities, maintaining accurate records supports clinical decision-making and contributes to the overall quality of veterinary care. ## Limitations of Respiratory Cytology Respiratory cytology has inherent limitations that should be recognized. The procedure samples only the cells present in the airway lumen and does not provide information about tissue architecture. Some diseases, particularly fibrotic or interstitial processes, may not exfoliate cells into the airway. The sensitivity of BAL cytology for detecting neoplasia is variable and depends on tumor type and location. Cytology cannot always distinguish between similar cellular patterns. For example, neutrophilic inflammation can result from bacterial infection, aspiration, or noninfectious inflammatory disease. The presence of intracellular bacteria supports bacterial infection, but culture is needed for definitive diagnosis. Similarly, eosinophilic inflammation can result from asthma, parasitic infection, or hypersensitivity, and additional testing may be needed to determine the underlying cause. The interpretation of BAL cytology requires experience and familiarity with normal cellular morphology. Inexperienced observers may misinterpret artifacts or fail to recognize subtle abnormalities. Referral to a clinical pathologist or veterinary specialist may be appropriate for challenging cases. ## Professional Escalation Criteria Veterinarians should consider referral to a specialist when respiratory cytology results are inconclusive, when the patient fails to respond to appropriate therapy, or when advanced diagnostic procedures are needed. The Merck Veterinary Manual describes the role of specialty referral in managing complex veterinary cases [4]. Cornell University College of Veterinary Medicine resources similarly describe the availability of specialty diagnostic services for veterinary patients [5]. Specific indications for escalation include: - Persistent respiratory signs despite appropriate treatment based on cytologic findings - Cytologic findings suspicious for neoplasia that require histopathologic confirmation - Need for advanced imaging such as computed tomography to characterize pulmonary lesions - Need for bronchoscopic biopsy or other advanced sampling techniques - Patients with severe respiratory compromise requiring intensive care monitoring - Cases where the cytologic findings do not explain the clinical presentation The decision to refer should be discussed with the owner, including the expected benefits of specialty evaluation and the associated costs. Timely referral can improve diagnostic accuracy and treatment outcomes for complex respiratory cases. ## Decision Framework for Cytology-Guided Respiratory Case Management Respiratory cytology results become clinically useful only when they are translated into a structured management plan. A practical decision framework helps the veterinarian move from cellular pattern to diagnostic action, therapeutic choice, and follow-up monitoring without overstepping what the cytology can actually support. The framework below organizes the interpretation process into sequential decision points that can be applied consistently across canine and feline respiratory cases. ### Step 1: Classify the Predominant Cellular Pattern The first decision point is classification of the dominant inflammatory cell population. The BAL differential cell count determines which diagnostic branch the case follows. A neutrophilic pattern with degenerate neutrophils and intracellular bacteria directs the case toward infectious disease investigation with culture and susceptibility testing. A neutrophilic pattern without visible bacteria in a patient already receiving antimicrobials requires careful interpretation because prior therapy can suppress visible organisms while culture remains positive. An eosinophilic pattern directs the case toward asthma, eosinophilic bronchopneumopathy, or parasitic investigation depending on signalment and endemic parasite exposure. A macrophage-predominant pattern with hemosiderin-laden macrophages raises the question of pulmonary hemorrhage, and the clinician must distinguish procedure-related hemorrhage from disease-related bleeding. The classification step should include a quality check of the sample itself. A sample with heavy blood contamination, excessive epithelial cells, or poor cellular preservation cannot support reliable differential counts. The clinician should record the sample quality assessment before proceeding to interpretation. If the sample is inadequate, the decision framework directs the case back to repeat sampling instead of forcing interpretation of a compromised preparation. ### Step 2: Correlate Cytology with Clinical and Radiographic Data The second decision point requires integration of the cytologic pattern with the patient's signalment, history, physical examination findings, and thoracic radiographs. A neutrophilic BAL in a young dog with acute cough, fever, and cranioventral alveolar infiltrates supports bacterial pneumonia and justifies empirical antimicrobial therapy while culture results are pending. The same neutrophilic pattern in an older dog with a chronic cough and a pulmonary mass requires a different diagnostic branch that includes neoplasia in the differential list. A feline patient with eosinophilic BAL and a history of progressive cough fits the asthma pattern, but the same cytology in a cat with access to outdoor areas should prompt consideration of lungworm infection. The World Small Animal Veterinary Association global guidelines support standardized clinical approaches that integrate diagnostic findings with patient-specific factors [3]. The American Animal Hospital Association practice guidance similarly frames diagnostic decision-making within the context of individual patient presentation and life-stage considerations [2]. These professional standards reinforce the principle that cytology is one component of a complete diagnostic picture instead of a standalone answer. ### Step 3: Select the Diagnostic Branch The third decision point selects the specific diagnostic pathway based on the integrated assessment. Four branches cover the majority of respiratory cytology cases. The infectious branch applies when cytology shows neutrophilic inflammation with or without visible organisms and clinical findings support bacterial, fungal, or parasitic infection. This branch requires bacterial culture and antimicrobial susceptibility testing of the BAL fluid. The Merck Veterinary Manual describes culture as essential for confirming bacterial infection and guiding antimicrobial selection [4]. Fungal culture or serology may be indicated when fungal organisms are seen or when the patient has relevant geographic exposure. Parasitic investigation, including fecal examination or antigen testing, is appropriate when eosinophilic inflammation coincides with potential parasite exposure. The inflammatory branch applies when cytology shows eosinophilic or mixed inflammation without evidence of infection. This branch leads to diagnosis and management of conditions such as feline asthma, eosinophilic bronchopneumopathy, or chronic bronchitis. Treatment focuses on reducing airway inflammation with corticosteroids or other immunomodulatory agents and identifying potential triggers. Serial cytology can document response to therapy and guide treatment adjustment. The hemorrhagic branch applies when hemosiderin-laden macrophages are prominent. A study of BAL samples from dogs and cats with respiratory disease found hemosiderin in 52.9 percent of feline samples and 7.6 percent of canine samples, with cats 13.33 times more likely to have pulmonary hemosiderosis compared with dogs [10]. The study authors noted that hemosiderosis is associated with a diverse range of disease conditions, indicating that this finding is not specific for any particular diagnosis [10]. The hemorrhagic branch requires investigation of potential causes including cardiac disease, coagulopathy, pulmonary thromboembolism, trauma, or neoplasia. In dogs, the study identified increased respiratory rates, prolonged BAL times, concurrent transthoracic fine-needle aspiration, and cytologic diagnoses as factors associated with increased risk of hemosiderosis [10]. The neoplastic branch applies when cytology reveals atypical cells with malignant features or when clinical and radiographic findings strongly suggest neoplasia despite nondiagnostic cytology. This branch leads to histopathologic biopsy for definitive diagnosis because cytology cannot always distinguish reactive atypia from neoplasia. Bronchial brushing of visible endobronchial masses may yield a higher diagnostic rate than BAL alone, and the nomenclature system for canine endobronchial anatomy supports systematic bronchoscopic examination and targeted sampling [8]. ### Step 4: Establish the Monitoring Protocol The fourth decision point establishes how the case will be monitored after treatment is initiated. Serial BAL cytology provides objective documentation of airway inflammation and response to therapy. The monitoring interval depends on the disease process and the treatment protocol. Chronic conditions such as feline asthma or eosinophilic bronchopneumopathy may require repeat cytology at 4 to 8 week intervals after treatment changes to assess response. Acute bacterial pneumonia may be monitored by clinical improvement and repeat radiographs instead of repeat BAL, with cytology reserved for cases that fail to respond to appropriate antimicrobial therapy. The monitoring protocol should include standardized sample collection and preparation methods to ensure that serial results are comparable. A study comparing cytocentrifuged preparations with sediment smears in horses with severe equine asthma found poor concordance in differential cell counts between the two methods, although both allowed diagnostic recognition of severe neutrophilic lung disorders [11]. This finding means that a practice should use the same preparation method for serial samples to avoid introducing method-related variation into the comparison. ### Step 5: Define Escalation Criteria The fifth decision point defines when the case should be escalated to a specialist or advanced diagnostic testing. Escalation is appropriate when cytologic findings are inconclusive, when the patient fails to respond to appropriate therapy, when advanced imaging is needed to characterize pulmonary lesions, or when histopathologic confirmation of neoplasia is required. Cornell University College of Veterinary Medicine resources describe the availability of specialty diagnostic services for veterinary patients [5]. The Merck Veterinary Manual similarly describes the role of specialty referral in managing complex veterinary cases [4]. Specific escalation triggers include persistent respiratory signs despite treatment based on cytologic findings, cytologic findings suspicious for neoplasia that require histopathologic confirmation, need for computed tomography to characterize pulmonary lesions, need for bronchoscopic biopsy or advanced sampling techniques, and patients with severe respiratory compromise requiring intensive care monitoring. The decision to refer should be discussed with the owner, including the expected benefits of specialty evaluation and the associated costs. ### Record System for Cytology-Guided Management A structured record system supports consistent application of the decision framework and facilitates comparison of serial samples. The medical record should document the indication for sampling, the technique used, the volume of fluid instilled and recovered, the gross appearance of the fluid, and any complications encountered. The cytology report should include the total nucleated cell count, differential cell percentages, and a description of abnormal cellular features. The record should also document the decision branch selected and the rationale for that selection. This documentation supports continuity of care if the patient is referred to a specialist or seen by a different clinician at a later visit. The World Organisation for Animal Health emphasizes the importance of accurate records and surveillance in animal health [6]. While individual patient records are not typically reported to regulatory authorities, maintaining accurate records supports clinical decision-making and contributes to the overall quality of veterinary care. A practical record format includes the date of sampling, the clinical indication, the sampling technique, the preparation method, the differential cell counts, the presence of infectious organisms or hemosiderin, the decision branch selected, the treatment initiated, and the planned follow-up interval. This format allows rapid comparison of serial samples and documentation of response to therapy. ### Troubleshooting Common Framework Failures The decision framework fails when the clinician attempts to interpret cytology without adequate clinical correlation or when the sample quality is insufficient to support the diagnostic branch selected. A common failure pattern is overinterpretation of a neutrophilic BAL as bacterial pneumonia without culture confirmation. Cytology alone cannot definitively diagnose bacterial pneumonia, and the absence of visible bacteria does not exclude infection, particularly in patients who have received antimicrobial therapy before sampling. Another failure pattern is underinterpretation of hemosiderin-laden macrophages as procedure-related artifact. The high prevalence of hemosiderosis in feline BAL samples indicates that pulmonary hemorrhage is common in cats with respiratory disease and should prompt investigation instead of dismissal [10]. The study authors noted that hemosiderosis is associated with a diverse range of disease conditions, so the finding should trigger a systematic search for the underlying cause [10]. A third failure pattern is failure to escalate when the patient does not respond to therapy. Persistent respiratory signs despite appropriate treatment based on cytologic findings should trigger reassessment, which may include repeat sampling, advanced imaging, or specialist referral. Delayed escalation can prolong patient suffering and delay definitive diagnosis. ### Welfare Context for the Decision Framework The decision framework should be applied with attention to patient welfare throughout the diagnostic and treatment process. The World Organisation for Animal Health emphasizes that animal health and welfare should be prioritized in all veterinary procedures [6]. The American Veterinary Medical Association emphasizes that pet owners should maintain regular veterinary engagement for preventive care and early disease detection, which supports timely diagnostic intervention when respiratory signs appear [1]. The decision to pursue repeat sampling or advanced diagnostics should balance the diagnostic value of the procedure against the risks of anesthesia and instrumentation. Complications of tracheobronchoscopy are uncommon, but patients must be carefully monitored during the procedure because complications may be severe and life-threatening when they occur [8]. Owners should be informed of the risks and benefits of each diagnostic step before consent is obtained. ## Frequently Asked Questions ### What is the difference between a tracheal wash and bronchoalveolar lavage? A tracheal wash samples cells from the trachea and large airways, while bronchoalveolar lavage samples the bronchoalveolar space including the alveoli. BAL provides a more representative picture of parenchymal lung disease and is preferred for diagnosing interstitial or alveolar conditions. ### How much fluid is used for bronchoalveolar lavage in dogs and cats? The volume of lavage fluid varies with patient size. Small dogs and cats typically receive 10 to 20 mL in divided aliquots, while larger dogs may receive 20 to 50 mL. The recovered volume is typically 40 to 60 percent of the instilled volume. ### What does eosinophilic inflammation in BAL fluid indicate? Eosinophilic inflammation indicates an allergic or hypersensitivity response. In cats, this pattern is commonly associated with feline asthma. In dogs, eosinophilic bronchopneumopathy is a recognized condition. Parasitic infection can also cause eosinophilic airway inflammation. ### Can BAL cytology diagnose bacterial pneumonia definitively? BAL cytology can support a diagnosis of bacterial pneumonia when degenerate neutrophils with intracellular bacteria are identified. However, culture of BAL fluid is needed for definitive diagnosis and antimicrobial susceptibility testing. The absence of visible bacteria does not exclude infection. ### How quickly must BAL samples be processed? BAL samples should be processed within 30 to 60 minutes of collection to minimize cellular degeneration. Delayed processing can result in pyknosis, karyorrhexis, and loss of cytoplasmic detail, making accurate cell identification difficult. ### Is hemosiderin in BAL fluid a specific indicator of a particular disease? No. Hemosiderin-laden macrophages indicate previous pulmonary hemorrhage but are not specific for any particular disease. A study found hemosiderosis in 52.9 percent of feline BAL samples and 7.6 percent of canine samples, associated with a diverse range of conditions [10]. ### What are the risks of bronchoscopic BAL in dogs and cats? Complications of tracheobronchoscopy are uncommon but can be severe and life-threatening when they occur [8]. Potential complications include hypoxemia, bronchospasm, hemorrhage, pneumothorax, and cardiac arrhythmias. Patients must be carefully monitored during the procedure. ### When should a pulmonary mass be sampled by fine-needle aspiration instead of BAL? Fine-needle aspiration is preferred for peripheral pulmonary masses that are accessible percutaneously under imaging guidance. BAL may not sample cohesive tumors that do not exfoliate cells into the airway. Bronchial brushing of visible endobronchial masses can also provide diagnostic material. ## Related Veterinary Guides - [Cytology of the Respiratory Tract: Collection and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/cytology-respiratory-tract-veterinary) - [Dental Disease In Dogs And Cats](/knowledge/veterinary-medicine/dental-care/dental-disease-in-dogs-and-cats) - [Antimicrobial Stewardship in Respiratory Infections of Dogs and Cats](/knowledge/veterinary-medicine/clinical-pharmacology/antimicrobial-stewardship-respiratory-infections-dogs-cats) - [Leukogram Patterns in Dogs and Cats: A Diagnostic Guide](/knowledge/veterinary-medicine/clinical-pathology/leukogram-patterns-dogs-cats) - [Gabapentin Dosage Calculator for Cats & Dogs: Veterinary Dosage Guide](/knowledge/veterinary-medicine/calculators-clinical-tools/gabapentin-dosage-calculator-for-cats-dogs-veterinary-dosage-guide) ## References and Further Reading - [Pet Care](https://www.avma.org/resources-tools/pet-owners). American Veterinary Medical Association. - [AAHA Guidelines](https://www.aaha.org/resources). American Animal Hospital Association. - [Global Guidelines](https://wsava.org/global-guidelines). World Small Animal Veterinary Association. - [Merck Veterinary Manual](https://www.merckvetmanual.com/). Merck Veterinary Manual. - [Cornell University College of Veterinary Medicine](https://www.vet.cornell.edu/). Cornell University. - [Animal Health and Welfare](https://www.woah.org/en/what-we-do/animal-health-and-welfare). World Organisation for Animal Health. - [Single-cell transcriptomics of bronchoalveolar lavage during PRRSV infection with different virulence.](https://pubmed.ncbi.nlm.nih.gov/39875369). Nature communications, 2025. - [Tracheobronchoscopy.](https://pubmed.ncbi.nlm.nih.gov/2238372). The Veterinary clinics of North America. Small animal practice, 1990. - [Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.](https://pubmed.ncbi.nlm.nih.gov/32527928). Science (New York, N.Y.), 2020. - [Bronchoalveolar lavage hemosiderosis in dogs and cats with respiratory disease.](https://pubmed.ncbi.nlm.nih.gov/30657606). Veterinary clinical pathology, 2019. - [Bronchoalveolar Lavage Cytology in Severe Equine Asthma: Cytocentrifugated versus Sediment Smear Preparations.](https://pubmed.ncbi.nlm.nih.gov/37624314). Veterinary sciences, 2023. > This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.